{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:01:43Z","timestamp":1785391303996,"version":"3.55.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is increasingly understood as a biologically defined and heterogeneous continuum, requiring models that move beyond symptom-based diagnosis toward individualized risk prediction, stratification, and intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This mini-review outlines how precision neuroscience frameworks may support the characterization of AD by integrating multimodal biomarkers, systems biology, systems neurophysiology, digital health markers, and artificial intelligence (AI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We synthesize recent developments across multi-omics profiling, neuroimaging and electrophysiological biomarkers, AI-based speech analysis, and multimodal machine learning approaches, with emphasis on their potential contribution to biologically informed disease staging and personalized clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Omics and systems biology approaches are expanding the characterization of molecular pathways involved in AD susceptibility, progression, and treatment response. Systems neurophysiology, including multimodal neuroimaging, electrophysiology, and whole-brain modeling, provides complementary markers of large-scale network disruption across the AD continuum. Digital health technologies, particularly AI-based speech analysis, offer scalable and ecologically valid tools for early risk enrichment and longitudinal monitoring. Multimodal AI models further enable the integration of heterogeneous clinical, molecular, imaging, genetic, and behavioral data into probabilistic representations of disease burden and progression. However, clinical translation remains constrained by interpretability, harmonization, validation, fairness, and accessibility challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Precision neuroscience offers a promising framework for reconceptualizing AD as a dynamically modeled and biologically stratified disorder. Future progress will depend on robust multimodal datasets, transparent AI methods, longitudinal validation, and equitable implementation strategies capable of supporting early detection, trial enrichment, and personalized prevention or treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1903637","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:40:44Z","timestamp":1785390044000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Toward precision neuroscience in Alzheimer\u2019s disease: the role of multimodal AI"],"prefix":"10.3389","volume":"18","author":[{"given":"Noelia","family":"Mart\u00ednez-Molina","sequence":"first","affiliation":[{"name":"Digital Health Unit, Eurecat Technology Center","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Orte","sequence":"additional","affiliation":[{"name":"Digital Health Unit, Eurecat Technology Center","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Migliorelli","sequence":"additional","affiliation":[{"name":"Digital Health Unit, Eurecat Technology Center","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicent","family":"Ribas","sequence":"additional","affiliation":[{"name":"Digital Health Unit, Eurecat Technology Center","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3233\/JAD-121750","article-title":"Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer\u2019s disease.","volume":"34","author":"Babiloni","year":"2013","journal-title":"J. Alzheimers Dis. JAD"},{"key":"B2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nn.4502","article-title":"Network neuroscience.","volume":"20","author":"Bassett","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"giag059","DOI":"10.1093\/gigascience\/giag059","article-title":"Cell type transcriptomic modules reveal shared molecular mechanisms in Alzheimer\u2019s and Parkinson\u2019s disease.","volume":"15","author":"Bhattacharya","year":"2026","journal-title":"GigaScience"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.tics.2022.09.015","article-title":"Over-reliance on English hinders cognitive science.","volume":"26","author":"Blasi","year":"2022","journal-title":"Trends Cogn. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jalz.2018.05.014","article-title":"Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer\u2019s disease in cognitively normal older adults with subjective memory complaints.","volume":"14","author":"Cavedo","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41398-019-0485-7","article-title":"Alzheimer\u2019s disease polygenic risk score as a predictor of conversion from mild-cognitive impairment.","volume":"9","author":"Chaudhury","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2012.02.009","article-title":"Personal omics profiling reveals dynamic molecular and medical phenotypes.","volume":"148","author":"Chen","year":"2012","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fnagi.2015.00130","article-title":"Menopause, obesity and inflammation: Interactive risk factors for Alzheimer\u2019s disease.","volume":"7","author":"Christensen","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.copbio.2019.03.004","article-title":"Big data analytics for personalized medicine.","volume":"58","author":"Cirillo","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine.","volume":"372","author":"Collins","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores.","volume":"12","author":"de Rojas","year":"2021","journal-title":"Nat. Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1016\/j.neuron.2022.09.012","article-title":"Challenges for machine learning in clinical translation of big data imaging studies.","volume":"110","author":"Dinsdale","year":"2022","journal-title":"Neuron"},{"key":"B13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease - the gateway to precision medicine.","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"fcac231","DOI":"10.1093\/braincomms\/fcac231","article-title":"Leveraging speech and artificial intelligence to screen for early Alzheimer\u2019s disease and amyloid beta positivity.","volume":"4","author":"Fristed","year":"2022","journal-title":"Brain Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"eaau8650","DOI":"10.1126\/science.aau8650","article-title":"The NASA twins study: A multidimensional analysis of a year-long human spaceflight.","volume":"364","author":"Garrett-Bakelman","year":"2019","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41583-026-01049-x","article-title":"Linking the exposome to the brain\u2013behaviour phenotype.","volume":"27","author":"Genon","year":"2026","journal-title":"Nat. Rev. Neurosci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tins.2022.12.004","article-title":"The foundation and architecture of precision medicine in neurology and psychiatry.","volume":"46","author":"Hampel","year":"2023","journal-title":"Trends Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"101346","DOI":"10.1016\/j.arr.2021.101346","article-title":"Omics sciences for systems biology in Alzheimer\u2019s disease: State-of-the-art of the evidence.","volume":"69","author":"Hampel","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-181121","article-title":"The alzheimer precision medicine initiative.","volume":"68","author":"Hampel","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e12013","DOI":"10.1002\/trc2.12013","article-title":"A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer\u2019s disease therapy: Analysis of the blarcamesine (ANAVEX2-73) phase 2a clinical study.","volume":"6","author":"Hampel","year":"2020","journal-title":"Alzheimers Dement."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e100784","DOI":"10.1136\/bmjhci-2023-100784","article-title":"Road map for clinicians to develop and evaluate AI predictive models to inform clinical decision-making.","volume":"30","author":"Hassan","year":"2023","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e70975","DOI":"10.1002\/alz.70975","article-title":"Development of language composites for enhanced sensitivity to multiple plasma biomarkers.","volume":"21","author":"He","year":"2025","journal-title":"Alzheimers Dement."},{"key":"B23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/jamaneurol.2018.0821","article-title":"Sex-specific association of apolipoprotein e with cerebrospinal fluid levels of tau.","volume":"75","author":"Hohman","year":"2018","journal-title":"JAMA Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrclinonc.2010.227","article-title":"Predictive, personalized, preventive, participatory (P4) cancer medicine.","volume":"8","author":"Hood","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: Toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"7407","DOI":"10.1038\/s41467-025-62590-4","article-title":"AI-driven fusion of multimodal data for Alzheimer\u2019s disease biomarker assessment.","volume":"16","author":"Jasodanand","year":"2025","journal-title":"Nat. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0688242024","DOI":"10.1523\/JNEUROSCI.0688-24.2024","article-title":"A shift toward supercritical brain dynamics predicts Alzheimer\u2019s disease progression.","volume":"45","author":"Javed","year":"2025","journal-title":"J. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1126\/science.aaa8415","article-title":"Machine learning: Trends, perspectives, and prospects.","volume":"349","author":"Jordan","year":"2015","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ana.24188","article-title":"A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for alzheimer disease.","volume":"76","author":"Karran","year":"2014","journal-title":"Ann. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e71462","DOI":"10.1002\/alz.71462","article-title":"Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts.","volume":"22","author":"K\u00f6nig","year":"2026","journal-title":"Alzheimers Dement."},{"key":"B33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41746-019-0084-2","article-title":"Digital biomarkers for Alzheimer\u2019s disease: The mobile\/wearable devices opportunity.","volume":"2","author":"Kourtis","year":"2019","journal-title":"NPJ Digit. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the lancet standing commission.","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnhum.2019.00017","article-title":"The importance of the validation of M\/EEG with current biomarkers in Alzheimer\u2019s disease.","volume":"13","author":"Maest\u00fa","year":"2019","journal-title":"Front. Hum. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.64898\/2025.12.11.25342039","article-title":"Disrupted brain hierarchical organization in Alzheimer\u2019s disease progression.","author":"Monta\u00f1a-Valverde","year":"2025","journal-title":"medRxiv."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s43587-025-00951-w","article-title":"Plasma tau biomarkers for biological staging of Alzheimer\u2019s disease.","volume":"5","author":"Montoliu-Gaya","year":"2025","journal-title":"Nat. Aging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cortex.2020.07.008","article-title":"Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer\u2019s disease.","volume":"131","author":"Mueller","year":"2020","journal-title":"Cortex."},{"key":"B39","doi-asserted-by":"publisher","first-page":"105225","DOI":"10.1016\/j.nbd.2020.105225","article-title":"Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration.","volume":"149","author":"Noori","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13195-023-01349-9","article-title":"Whole-brain modeling of the differential influences of amyloid-beta and tau in Alzheimer\u2019s disease.","volume":"15","author":"Patow","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11747-019-00710-5","article-title":"Explainable AI: From black box to glass box.","volume":"48","author":"Rai","year":"2020","journal-title":"J. Acad. Mark. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s44400-025-00040-0","article-title":"Voiceprints of cognitive impairment: Analyzing digital voice for early detection of Alzheimer\u2019s and related dementias.","volume":"1","author":"Rezaii","year":"2025","journal-title":"Npj Dement."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/s41593-019-0520-2","article-title":"A deep learning framework for neuroscience.","volume":"22","author":"Richards","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","article-title":"Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead.","volume":"1","author":"Rudin","year":"2019","journal-title":"Nat. Mach. Intell."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-024-06217-2","article-title":"Personalized whole-brain neural mass models reveal combined A\u03b2 and tau hyperexcitable influences in Alzheimer\u2019s disease.","volume":"7","author":"Sanchez-Rodriguez","year":"2024","journal-title":"Commun. Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","article-title":"Biomarker-based staging of alzheimer disease: Rationale and clinical applications.","volume":"20","author":"Therriault","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/s41591-024-03057-9","article-title":"Personalized brain circuit scores identify clinically distinct biotypes in depression and anxiety.","volume":"30","author":"Tozzi","year":"2024","journal-title":"Nat. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1002482","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in alzheimer disease: A targeted metabolomics study.","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1706.03762","article-title":"Attention is all you need.","author":"Vaswani","year":"2023","journal-title":"Adv. Neural Inf. Process. Syst"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jalz.2019.07.001","article-title":"Brain A\u03b2 load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD.","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"B51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/acm2.13121","article-title":"A review on medical imaging synthesis using deep learning and its clinical applications.","volume":"22","author":"Wang","year":"2021","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e677","DOI":"10.1016\/S2589-7500(20)30200-4","article-title":"Time to reality check the promises of machine learning-powered precision medicine.","volume":"2","author":"Wilkinson","year":"2020","journal-title":"Lancet Digit. Health"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1903637\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:40:45Z","timestamp":1785390045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1903637\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":52,"alternative-id":["10.3389\/fnagi.2026.1903637"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1903637","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1903637"}}